Herborium Group Inc (HBRM)
0.0001
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.2203M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 0.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 99.99% |
Profile
| Herborium Group Inc provides natural, & complementary healthcare-related products to consumers & healthcare professionals seeking alternative answers to the management of healthcare issues not currently met by standard Western medicine. Its focus is on developing, licensing, & marketing proprietary, botanical-based medicinal products, targeting unmet medical needs. Its products are botanical supplements comprised of herbal formulations, referred as botanical therapeutics. Substantially all of the company's revenue has been derived from the sale of AcnEase through its corporate website. The Company responds to both consumer & healthcare professionals demand for safe, efficacious, all-natural medicinal options for the treatment and prevention of selected diseases & health concerns. |
| URL | https://www.herborium.com |
| Investor Relations URL | N/A |
| HQ State/Province | Texas |
| Sector | Consumer Staples |
| Industry | Personal Care Products |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Herborium Group Inc provides natural, & complementary healthcare-related products to consumers & healthcare professionals seeking alternative answers to the management of healthcare issues not currently met by standard Western medicine. Its focus is on developing, licensing, & marketing proprietary, botanical-based medicinal products, targeting unmet medical needs. Its products are botanical supplements comprised of herbal formulations, referred as botanical therapeutics. Substantially all of the company's revenue has been derived from the sale of AcnEase through its corporate website. The Company responds to both consumer & healthcare professionals demand for safe, efficacious, all-natural medicinal options for the treatment and prevention of selected diseases & health concerns. |
| URL | https://www.herborium.com |
| Investor Relations URL | N/A |
| HQ State/Province | Texas |
| Sector | Consumer Staples |
| Industry | Personal Care Products |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |